Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis
Launched by OCTOBER 6 UNIVERSITY · Nov 23, 2013
Trial Information
Current as of June 12, 2025
Unknown status
Keywords
ClinConnect Summary
The study include:
200 knees, 50 knees will have single injection of Crespine gel, and 50 knees will have single injection of 2 ampules of Intragel, also 50 knees will have single injection of Crespine plus gel and 50 knees will have single injection of Monovisc The patient will be randomized to Crespine gel or to Intragel, and Crespine Plus gel or to Monovisc
Inclusion Criteria: patients with Osteoarthritis grade II and III according to Kellgren and Lawrence grading were included.
Exclusion Criteria: patients with autoimmune illnesses, active inflammation or infected processes, anticoag...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of patients between 20 and 70 years
- • patients with Osteoarthritis grade II and III according to Kellgren and Lawrence grading
- Exclusion Criteria:
- • Autoimmune illnesses
- • Active inflammation or infected processes
- • Anticoagulant
- • Known allergy to hyaluronic acid.
About October 6 University
October 6 University is a prestigious educational institution dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and excellence, the university fosters a collaborative environment that integrates cutting-edge scientific research with practical clinical applications. Its commitment to improving healthcare outcomes is reflected in its comprehensive approach to clinical trials, where it engages in rigorous methodologies and ethical standards to ensure the safety and efficacy of new treatments. Through its dedicated research facilities and highly qualified personnel, October 6 University aims to contribute significantly to the global medical community and enhance patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Six October City, , Egypt
Patients applied
Trial Officials
Mahmoud A Hafez, Professor
Principal Investigator
October 6 University
Abdullah I Ammoura, Researcher
Study Chair
Bone and Joint Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials